These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 29538617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Conventional karyotyping and fluorescence in situ hybridization: an effective utilization strategy in diagnostic adult acute myeloid leukemia.
    He R, Wiktor AE, Hanson CA, Ketterling RP, Kurtin PJ, Van Dyke DL, Litzow MR, Howard MT, Reichard KK.
    Am J Clin Pathol; 2015 Jun; 143(6):873-8. PubMed ID: 25972330
    [Abstract] [Full Text] [Related]

  • 3. [Multiprobe fluorescence in situ hybridization panel in detection of the common cytogenetic abnormalities of acute myeloid leukemia].
    Xu LL, Liu XL, Du QF, Song LL, Cao R, Wei YQ, Xu N, Zhang JF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):324-6. PubMed ID: 21638933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C, Haferlach T, Bursch S, Gerstner D, Schnittger S, Dugas M, Kern W, Löffler H, Hiddemann W.
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [Abstract] [Full Text] [Related]

  • 7. Detection of recurrent cytogenetic abnormalities in acute lymphoblastic and myeloid leukemias using fluorescence in situ hybridization.
    Vance GH.
    Methods Mol Biol; 2013 Sep; 999():79-91. PubMed ID: 23666691
    [Abstract] [Full Text] [Related]

  • 8. Dual color FISH on CBF primary acute myeloid leukemia.
    Sorour A, Nafea D.
    Egypt J Immunol; 2008 Sep; 15(2):25-31. PubMed ID: 20306685
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Optimization of pre-coated multi-probe fluorescence in situ hybridization for cytogenetic detection of acute leukemia].
    Cao R, Song L, Wu F, Liao L, Zuo Y, Liu X.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Oct; 32(10):1457-60. PubMed ID: 23076184
    [Abstract] [Full Text] [Related]

  • 11. Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia.
    Bernell P, Arvidsson I, Jacobsson B, Hast R.
    Br J Haematol; 1996 Dec; 95(4):666-72. PubMed ID: 8982043
    [Abstract] [Full Text] [Related]

  • 12. [Clinical value of interphase fluorescent in situ hybridization in diagnosis of core-binding factor acute myelocytic leukemia].
    Yang H, Fan L, Qiu HR, Wang R, Zhang JF, Wu YJ, Li JY, Liu P.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1156-60. PubMed ID: 22040962
    [Abstract] [Full Text] [Related]

  • 13. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia.
    Aypar U, Smoley SA, Pitel BA, Pearce KE, Zenka RM, Vasmatzis G, Johnson SH, Smadbeck JB, Peterson JF, Geiersbach KB, Van Dyke DL, Thorland EC, Jenkins RB, Ketterling RP, Greipp PT, Kearney HM, Hoppman NL, Baughn LB.
    Eur J Haematol; 2019 Jan; 102(1):87-96. PubMed ID: 30270457
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
    Seegmiller AC, Wasserman A, Kim AS, Kressin MK, Marx ER, Zutter MM, Mosse CA.
    Leuk Lymphoma; 2014 Mar; 55(3):601-5. PubMed ID: 23876099
    [Abstract] [Full Text] [Related]

  • 16. Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study.
    Vundinti BR, Korgaonkar S, Dhangar S, Jijina F, Shanmukhaiah C.
    J Cancer Res Ther; 2023 Mar; 19(2):340-346. PubMed ID: 37006070
    [Abstract] [Full Text] [Related]

  • 17. Acute promyelocytic leukemia: the study of t(15;17) translocation by fluorescent in situ hybridization, reverse transcriptase-polymerase chain reaction and cytogenetic techniques.
    Chauffaille ML, Figueiredo MS, Beltrani R, Antunes SV, Yamamoto M, Kerbauy J.
    Braz J Med Biol Res; 2001 Jun; 34(6):735-43. PubMed ID: 11378661
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Luquet I, Bidet A, Cuccuini W, Lafage-Pochitaloff M, Mozziconacci MJ, Terré C.
    Ann Biol Clin (Paris); 2016 Oct 01; 74(5):535-546. PubMed ID: 27545007
    [Abstract] [Full Text] [Related]

  • 19. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
    Klaus M, Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C.
    Cancer Genet Cytogenet; 2004 Nov 01; 155(1):47-56. PubMed ID: 15527902
    [Abstract] [Full Text] [Related]

  • 20. [Fluorescence in situ hybridization study of acute myeloid leukemia with cryptic chromosome rearrangements].
    Bai SX, Xue YQ, Chen SN, Pan JL, Wu YF, Shen J, Wang Y, Zhang J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec 01; 28(6):690-3. PubMed ID: 22161107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.